GB1245292A - Halogeno-pregnadienes and process for the manufacture thereof - Google Patents
Halogeno-pregnadienes and process for the manufacture thereofInfo
- Publication number
- GB1245292A GB1245292A GB54564/68A GB5456468A GB1245292A GB 1245292 A GB1245292 A GB 1245292A GB 54564/68 A GB54564/68 A GB 54564/68A GB 5456468 A GB5456468 A GB 5456468A GB 1245292 A GB1245292 A GB 1245292A
- Authority
- GB
- United Kingdom
- Prior art keywords
- double bond
- steroids
- group
- esterified
- free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 230000008030 elimination Effects 0.000 abstract 2
- 238000003379 elimination reaction Methods 0.000 abstract 2
- LBVVIQNARGTNEX-NXILKQGXSA-N (8R,9S,10S,13S,14S)-2-chloro-17-ethenyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthrene Chemical class ClC1CCC2CC[C@H]3[C@@H]4CC=C(C=C)[C@]4(CC[C@@H]3[C@]2(C1)C)C LBVVIQNARGTNEX-NXILKQGXSA-N 0.000 abstract 1
- JUYWGBDEJMLRQV-OTMNYJCCSA-N (8S,9S,10R,13R,14S,17S)-1,2-dichloro-17-ethyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene Chemical compound ClC1C(CC=C2CC[C@H]3[C@@H]4CC[C@H](CC)[C@]4(CC[C@@H]3[C@@]12C)C)Cl JUYWGBDEJMLRQV-OTMNYJCCSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000001741 anti-phlogistic effect Effects 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 230000003096 thymolvtic effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
- H01R33/00—Coupling devices specially adapted for supporting apparatus and having one part acting as a holder providing support and electrical connection via a counterpart which is structurally associated with the apparatus, e.g. lamp holders; Separate parts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1610167A CH510655A (de) | 1967-11-17 | 1967-11-17 | Verfahren zur Herstellung neuer Halogenpregnadiene |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1245292A true GB1245292A (en) | 1971-09-08 |
Family
ID=4414467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB54564/68A Expired GB1245292A (en) | 1967-11-17 | 1968-11-18 | Halogeno-pregnadienes and process for the manufacture thereof |
Country Status (15)
Country | Link |
---|---|
US (1) | US3652554A (en:Method) |
JP (1) | JPS4829221B1 (en:Method) |
AT (3) | AT298695B (en:Method) |
BE (1) | BE723905A (en:Method) |
BR (1) | BR6804024D0 (en:Method) |
CH (4) | CH513845A (en:Method) |
DK (1) | DK129835B (en:Method) |
FR (2) | FR1594773A (en:Method) |
GB (1) | GB1245292A (en:Method) |
MY (1) | MY7400317A (en:Method) |
NL (1) | NL161767C (en:Method) |
PL (1) | PL80570B1 (en:Method) |
SE (1) | SE351634B (en:Method) |
SU (1) | SU424352A3 (en:Method) |
YU (4) | YU34138B (en:Method) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102827229A (zh) * | 2011-06-17 | 2012-12-19 | 重庆华邦胜凯制药有限公司 | 一种纯化卤米松羧酸酯的方法 |
CN111944004A (zh) * | 2020-09-25 | 2020-11-17 | 湖南新合新生物医药有限公司 | 一种卤米松的制备方法 |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2010458B2 (de) * | 1970-02-28 | 1979-04-26 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue 21-Halogensteroide |
CH558787A (de) * | 1970-12-10 | 1975-02-14 | Ciba Geigy Ag | Verfahren zur herstellung eines neuen halogenpregnadiens. |
GB1377608A (en) * | 1970-12-17 | 1974-12-18 | Glaxo Lab Ltd | 3alpha-hydroxy or acyloxy pregnene-21-ethers |
NL7502252A (nl) * | 1974-02-27 | 1975-08-29 | Pierrel Spa | Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden. |
SE418294B (sv) * | 1974-03-27 | 1981-05-18 | Plurichemie Anstalt | Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester |
FR2291760A1 (fr) * | 1974-11-19 | 1976-06-18 | Pierrel Spa | Nouveaux steroides a base de 2-chloro-6 b-fluoro-pregna-1,4-diene-3,20-diones |
GB1505701A (en) * | 1975-06-14 | 1978-03-30 | Pierrel Spa | 2-chloro-6beta-fluoropregnanes |
DE2655570A1 (de) * | 1975-12-12 | 1977-06-16 | Ciba Geigy Ag | Neue polyhalogensteroide und verfahren zu ihrer herstellung |
WO2005021515A2 (en) * | 2003-08-29 | 2005-03-10 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-iv |
US20070259874A1 (en) * | 2003-11-26 | 2007-11-08 | Palle Venkata P | Phosphodiesterase Inhibitors |
WO2007031838A1 (en) | 2005-09-16 | 2007-03-22 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
AU2006305619A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
JP2009512677A (ja) * | 2005-10-19 | 2009-03-26 | ランバクシー ラボラトリーズ リミテッド | ホスホジエステラーゼタイプiv阻害剤の組成物 |
WO2008035316A2 (en) * | 2006-09-22 | 2008-03-27 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
MX2009003100A (es) * | 2006-09-22 | 2009-05-11 | Ranbaxy Lab Ltd | Inhibidores de fosfodiesterasa tipo iv. |
EP1958947A1 (en) | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 |
WO2008111009A1 (en) * | 2007-03-14 | 2008-09-18 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
KR101568884B1 (ko) | 2007-03-14 | 2015-11-12 | 랜박시 래보러터리스 리미티드 | 포스포디에스테라제 저해제로서 피라졸로 (3,4-b) 피리딘 유도체 |
EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
CN104370987B (zh) * | 2014-10-22 | 2016-09-14 | 湖南明瑞制药有限公司 | 一种卤米松的精制方法 |
-
1967
- 1967-11-17 CH CH1746770A patent/CH513845A/de not_active IP Right Cessation
- 1967-11-17 CH CH1746670A patent/CH540244A/de not_active IP Right Cessation
- 1967-11-17 CH CH1610167A patent/CH510655A/de not_active IP Right Cessation
- 1967-11-17 CH CH251171A patent/CH534144A/de not_active IP Right Cessation
-
1968
- 1968-09-14 FR FR1594773D patent/FR1594773A/fr not_active Expired
- 1968-11-06 SE SE15016/68A patent/SE351634B/xx unknown
- 1968-11-14 BR BR204024/68A patent/BR6804024D0/pt unknown
- 1968-11-14 BE BE723905D patent/BE723905A/xx not_active IP Right Cessation
- 1968-11-15 AT AT183070A patent/AT298695B/de not_active IP Right Cessation
- 1968-11-15 PL PL1968130064A patent/PL80570B1/pl unknown
- 1968-11-15 SU SU1387327A patent/SU424352A3/ru active
- 1968-11-15 DK DK559768AA patent/DK129835B/da not_active IP Right Cessation
- 1968-11-15 YU YU2673/68A patent/YU34138B/xx unknown
- 1968-11-15 US US776270A patent/US3652554A/en not_active Expired - Lifetime
- 1968-11-15 AT AT00470/70A patent/AT298690B/de not_active IP Right Cessation
- 1968-11-15 NL NL6816337.A patent/NL161767C/xx not_active IP Right Cessation
- 1968-11-15 AT AT1113168A patent/AT293633B/de not_active IP Right Cessation
- 1968-11-18 GB GB54564/68A patent/GB1245292A/en not_active Expired
-
1969
- 1969-02-13 FR FR183253A patent/FR8278M/fr not_active Expired
-
1971
- 1971-07-16 JP JP46053047A patent/JPS4829221B1/ja active Pending
-
1974
- 1974-12-30 MY MY317/74A patent/MY7400317A/xx unknown
-
1975
- 1975-02-11 YU YU00308/75A patent/YU30875A/xx unknown
- 1975-02-11 YU YU00307/75A patent/YU30775A/xx unknown
- 1975-02-11 YU YU00306/75A patent/YU30675A/xx unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102827229A (zh) * | 2011-06-17 | 2012-12-19 | 重庆华邦胜凯制药有限公司 | 一种纯化卤米松羧酸酯的方法 |
CN102827229B (zh) * | 2011-06-17 | 2016-01-20 | 重庆华邦胜凯制药有限公司 | 一种纯化卤米松羧酸酯的方法 |
CN111944004A (zh) * | 2020-09-25 | 2020-11-17 | 湖南新合新生物医药有限公司 | 一种卤米松的制备方法 |
CN111944004B (zh) * | 2020-09-25 | 2023-11-17 | 湖南新合新生物医药有限公司 | 一种卤米松的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
BR6804024D0 (pt) | 1973-01-02 |
YU267368A (en) | 1978-06-30 |
NL6816337A (en:Method) | 1969-05-20 |
YU34138B (en) | 1978-12-31 |
YU30675A (en) | 1982-05-31 |
DE1807980A1 (de) | 1969-06-04 |
SU424352A3 (en:Method) | 1974-04-15 |
CH534144A (de) | 1973-02-28 |
YU30775A (en) | 1982-05-31 |
NL161767C (nl) | 1980-03-17 |
MY7400317A (en) | 1974-12-31 |
FR1594773A (en:Method) | 1970-06-08 |
FR8278M (en:Method) | 1970-11-02 |
PL80570B1 (en:Method) | 1975-08-30 |
AT293633B (de) | 1971-10-25 |
DK129835C (en:Method) | 1975-05-05 |
CH540244A (de) | 1973-08-15 |
DK129835B (da) | 1974-11-25 |
YU30875A (en) | 1982-05-31 |
AT298695B (de) | 1972-05-25 |
AT298690B (de) | 1972-04-15 |
CH513845A (de) | 1971-10-15 |
US3652554A (en) | 1972-03-28 |
BE723905A (en:Method) | 1969-05-14 |
CH510655A (de) | 1971-07-31 |
SE351634B (en:Method) | 1972-12-04 |
DE1807980B2 (de) | 1975-11-06 |
JPS4829221B1 (en:Method) | 1973-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1245292A (en) | Halogeno-pregnadienes and process for the manufacture thereof | |
GB1268230A (en) | Steroid glycosides and process for their manufacture | |
GB1457022A (en) | Esters of oxyalkyltheophyllines the preparation thereof and pharmaceutical compositions containint them | |
GB1211219A (en) | 21-aldehydes of the pregnane series and derivatives thereof and process for their manufacture | |
NL179059C (nl) | Werkwijze ter bereiding van een geneesmiddel met ontstekingsremmende werking, gevormd geneesmiddel en werkwijze ter bereiding van geneeskrachtige verbindingen, geschikt voor gebruik bij deze werkwijze. | |
GB1294649A (en) | Perfluoralkylmonocarboxylic acid esters, processes for their manufacture and their use | |
GB1148117A (en) | D-homosteroids and process for their manufacture | |
GB1092574A (en) | 13,14-seco-steroids and process for their manufacture | |
GB1187659A (en) | Testosterone Derivatives | |
GB1282703A (en) | Salicil derivatives, the preparation thereof and antiparasitic compositions containing them | |
GB1311725A (en) | 18-cyano pregnane compounds and process for their manufacture | |
IE33379B1 (en) | New halogen-pregnadienes and process for their manufacture | |
GB1262576A (en) | New halogen-pregnadienes and processes for the manufacture thereof | |
GB1186180A (en) | Phosphorus-Containing Carboxylic Acid Esters and their use as Lubricating Oil Additives | |
GB1248418A (en) | 3-oxo-steroid-oximes and process for their manufacture | |
GB1289020A (en:Method) | ||
SE7710337L (sv) | Forfarande for framstellning av 9,11-halogenerade steroider | |
GB1215164A (en) | 21-sulphonated pregnadienes | |
GB1384994A (en) | Pregnane-21-aldehydes and their derivatives and a process for the production thereof | |
GB1162769A (en) | Delta<,5>-7alpha-Methyl-Estradienes and their preparation | |
GB1289918A (en:Method) | ||
GB1272688A (en) | Sulphamido-steroids and the preparation thereof | |
GB1320302A (en) | 21-fluoro-16,17-dihydroxy-pregnane compounds and their derivatives | |
GB1276743A (en) | Aldehydes of the pregnane series and process for their manufacture | |
GB1189217A (en) | 09-nor-Testosterone Phenoxyacetate and 6-Methyl Derivatives thereof |